Sep 26, 2019   SOURCE: PR NewsWire

Global Intravenous Solution Market to Surpass US$ 13,410.8 Million by 2027 - Coherent Market Insights

SEATTLE, Sept. 26, 2019 /PRNewswire/ -- According to Coherent Market Insights, the Global Intravenous Solution Market was valued at US$ 8,372.0 million in 2019, and is expected to exhibit a CAGR of 6.1% over the forecast period (2019 - 2027).

https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

Key Trends and Analysis of the Intravenous Solution Market:

Global intravenous solution market is expected to witness significant growth over the forecast period, owing to increasing incidence of diarrheal diseases. For instance, in 2016, according to the World Health Organization (WHO), around 1.4 million death occurred globally due to diarrheal diseases.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1134

Moreover, the global intravenous solution market is further expected to generate high revenue over the forecast period, owing to increasing positive clinical trials of IV infusions, which are driving the adoption of vitamin C intravenous therapy for treating cancer. For instance, in March 2017, the Weill Medical College of Cornell University initiated the Phase II study of high dose Vitamin C intravenous infusion for treatment of colorectal and pancreatic cancer, and this study is expected to complete by December 2021.

Several companies are focusing on agreement strategies to procure IV solutions and improve patient care with reduced costs, which is expected to drive growth of the intravenous solution market. For instance, in August 2019, B. Braun Medical Inc. and Steward Health Care entered into a purchasing agreement for seven years. Under this agreement, Steward Health Care will work with B. Braun Group of Companies in the U.S. in order to procure IV solutions and improve patient care with reduced costs.

Buy this Report Now (For Single User License) @ https://www.coherentmarketinsights.com/insight/buy-now/1134

Key Market Takeaways:

    --  The global intravenous solution market is expected to register a CAGR of
        6.1% over the forecast period (2019 - 2027), owing to increasing
        regulatory approvals for intravenous solution injections. For instance,
        in January 2018, Baxter International Inc. announced that the U.S. FDA
        approved its Bivalirudin in 0.9% Sodium Chloride Injection. Bivalirudin
        is indicated as an anticoagulant in patients, undergoing percutaneous
        coronary intervention (PCI).
    --  Among region, North America is expected to hold a dominant position in
        the global intravenous solution market over the forecast period, owing
        to increasing healthcare expenditure, frequent product approvals, and
        product launches. For instance, in November 2016, Mallinckrodt
        Pharmaceuticals,  an Irish-tax registered manufacturer of specialty
        pharmaceuticals, generic drugs and imaging agents, received the U.S.
        Food and Drug Administration's (FDA) prior approval supplement for
        OFIRMEV, an acetaminophen injection (new drug application) available in
        an intravenous (IV) bag.
    --  Major players operating in the global intravenous solution market
        include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen
        Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd,
        JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius
        Pharma Private Limited.

Report Segmentation:

    --  Global Intravenous Solution Market , By Solution Type:
        --  Saline
            --  Normal Saline (0.9% NaCl)
            --  Hypertonic Saline
        --  Dextran
        --  Lactated Ringer's
        --  Amino Acid
        --  Vitamins & Minerals
        --  Heparin and Trace Elements
        --  Mixed Solutions
    --  Global Intravenous Solution Market , By Bag Type:
        --  Large Volume Bags (greater than 250ml)
        --  Small Volume Bags (less than 250ml)
    --  Global Intravenous Solution Market , By Application:
        --  Basic IV Solution
        --  Nutritional IV Solution
        --  Blood IV Solution
        --  Drug IV Solution
        --  Irrigation IV Solution
    --  Global Intravenous Solution Market , By End-user:
        --  Hospitals
        --  Clinics
        --  Ambulatory Surgery Centers
        --  Home Care Settings
    --  Global Intravenous Solution Market , By Region:
        --  North America
            --  By Country:
                --  U.S.
                --  Canada
        --  Europe
            --  By Country:
                --  U.K.
                --  Germany
                --  Italy
                --  Spain
                --  France
                --  Russia
                --  Rest of Europe
        --  Asia Pacific
            --  By Country:
                --  Australia
                --  India
                --  China
                --  Japan
                --  ASEAN
                --  South Korea
                --  Rest of Asia Pacific
        --  Latin America
            --  By Country:
                --  Brazil
                --  Mexico
                --  Argentina
                --  Rest of Latin America
        --  Middle East
            --  By Country/Region:
                --  GCC
                --  Israel
                --  Rest of Middle East
        --  Africa
            --  By Country/Region:
                --  South Africa
                --  Central Africa
                --  North Africa
    --  Company Profiles

Contact Us:
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

View original content:http://www.prnewswire.com/news-releases/global-intravenous-solution-market-to-surpass-us-13-410-8-million-by-2027--coherent-market-insights-300925988.html

SOURCE Coherent Market Insights